Back to Search
CARLA MARIA CANUSO, M.D.
M.D.
Psychiatry Physician
NPI: 1952348914Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
81213(MA)
Research & Publications (18)
Efficacy and safety of paliperidone extended-release in schizophrenia patients with prominent affective symptoms.
PMID 19552963·J Affect Disord·2010
2-rct
Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.
PMID 19411369·Am J Psychiatry·2009
2-rct
Paliperidone extended-release for schizophrenia: effects on symptoms and functioning in acutely ill patients with negative symptoms.
PMID 19560322·Schizophr Res·2009
4-observational
Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone.
PMID 18545059·Int Clin Psychopharmacol·2008
4-observational
Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia.
PMID 19183785·Neuropsychiatr Dis Treat·2008
8-other
Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale.
PMID 18441528·Psychopathology·2008
8-other
Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression.
PMID 17928573·Am J Geriatr Psychiatry·2008
4-observational
Risperidone for treatment-refractory major depressive disorder: a randomized trial.
PMID 17975181·Ann Intern Med·2007
4-observational
Adjunctive risperidone in the treatment of generalized anxiety disorder: a double-blind, prospective, placebo-controlled, randomized trial.
PMID 18007568·Psychopharmacol Bull·2007
2-rct
Limitations in discerning the effects of risperidone and its 9-hydroxy metabolite on prolactin levels in a small study of patients with schizophrenia.
PMID 17599334·Hum Psychopharmacol·2007
8-other
Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation.
PMID 16760927·Neuropsychopharmacology·2006
4-observational
Methodological issues in a comparative study of ziprasidone and risperidone.
PMID 16426103·J Clin Psychiatry·2006
4-observational
An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.
PMID 16317312·Int Clin Psychopharmacol·2006
4-observational
Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
PMID 15169694·Am J Psychiatry·2004
3-trial
Detection and management of comorbidity in patients with schizophrenia.
PMID 12683263·Psychiatr Clin North Am·2003
6-review
Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder.
PMID 12140115·Psychiatry Res·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- JANSSEN PHARMACEUTICALS
TITUSVILLE, NJ 08560 - Phone
- (609) 730-7732
Quick Facts
- NPI
- 1952348914
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile